Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Loading...
Embargo End Date
Authors
Gregucci, F
Spada, S
Barcellos-Hoff, MH
Bhardwaj, N
Chan Wah Hak, C
Fiorentino, A
Guha, C
Guzman, ML
Harrington, K
Herrera, FG
Honeychurch, J
Hong, T
Iturri, L
Jaffee, E
Karam, SD
Knott, SRV
Koumenis, C
Lyden, D
Marciscano, AE
Melcher, A
Mondini, M
Mondino, A
Morris, ZS
Pitroda, S
Quezada, SA
Santambrogio, L
Shiao, S
Stagg, J
Telarovic, I
Timmerman, R
Vozenin, M-C
Weichselbaum, R
Welsh, J
Wilkins, A
Xu, C
Zappasodi, R
Zou, W
Bobard, A
Demaria, S
Galluzzi, L
Deutsch, E
Formenti, SC
Spada, S
Barcellos-Hoff, MH
Bhardwaj, N
Chan Wah Hak, C
Fiorentino, A
Guha, C
Guzman, ML
Harrington, K
Herrera, FG
Honeychurch, J
Hong, T
Iturri, L
Jaffee, E
Karam, SD
Knott, SRV
Koumenis, C
Lyden, D
Marciscano, AE
Melcher, A
Mondini, M
Mondino, A
Morris, ZS
Pitroda, S
Quezada, SA
Santambrogio, L
Shiao, S
Stagg, J
Telarovic, I
Timmerman, R
Vozenin, M-C
Weichselbaum, R
Welsh, J
Wilkins, A
Xu, C
Zappasodi, R
Zou, W
Bobard, A
Demaria, S
Galluzzi, L
Deutsch, E
Formenti, SC
Document Type
Journal Article
Date
2023-12-31
Date Accepted
2023-06-02
Abstract
Focal radiation therapy (RT) has attracted considerable attention as a combinatorial partner for immunotherapy (IT), largely reflecting a well-defined, predictable safety profile and at least some potential for immunostimulation. However, only a few RT-IT combinations have been tested successfully in patients with cancer, highlighting the urgent need for an improved understanding of the interaction between RT and IT in both preclinical and clinical scenarios. Every year since 2016, ImmunoRad gathers experts working at the interface between RT and IT to provide a forum for education and discussion, with the ultimate goal of fostering progress in the field at both preclinical and clinical levels. Here, we summarize the key concepts and findings presented at the Sixth Annual ImmunoRad conference.
Citation
OncoImmunology, 2023, 12 (1), pp. 2222560 -
Source Title
OncoImmunology
Publisher
TAYLOR & FRANCIS INC
ISSN
2162-4011
eISSN
2162-402X
2162-402X
2162-402X
Collections
Research Team
Trans Immunotherapy
Targeted Therapy
Targeted Therapy